1. Home
  2. RBCAA vs SYRE Comparison

RBCAA vs SYRE Comparison

Compare RBCAA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBCAA
  • SYRE
  • Stock Information
  • Founded
  • RBCAA 1974
  • SYRE 2013
  • Country
  • RBCAA United States
  • SYRE United States
  • Employees
  • RBCAA N/A
  • SYRE N/A
  • Industry
  • RBCAA Major Banks
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBCAA Finance
  • SYRE Health Care
  • Exchange
  • RBCAA Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • RBCAA 1.3B
  • SYRE 1.3B
  • IPO Year
  • RBCAA 1998
  • SYRE 2016
  • Fundamental
  • Price
  • RBCAA $65.66
  • SYRE $21.29
  • Analyst Decision
  • RBCAA
  • SYRE Strong Buy
  • Analyst Count
  • RBCAA 0
  • SYRE 8
  • Target Price
  • RBCAA N/A
  • SYRE $51.50
  • AVG Volume (30 Days)
  • RBCAA 22.7K
  • SYRE 574.3K
  • Earning Date
  • RBCAA 01-24-2025
  • SYRE 03-03-2025
  • Dividend Yield
  • RBCAA 2.75%
  • SYRE N/A
  • EPS Growth
  • RBCAA 12.83
  • SYRE N/A
  • EPS
  • RBCAA 5.14
  • SYRE N/A
  • Revenue
  • RBCAA $330,428,000.00
  • SYRE N/A
  • Revenue This Year
  • RBCAA N/A
  • SYRE $168.62
  • Revenue Next Year
  • RBCAA $3.87
  • SYRE $47.61
  • P/E Ratio
  • RBCAA $12.78
  • SYRE N/A
  • Revenue Growth
  • RBCAA 6.29
  • SYRE N/A
  • 52 Week Low
  • RBCAA $46.55
  • SYRE $20.13
  • 52 Week High
  • RBCAA $80.68
  • SYRE $47.97
  • Technical
  • Relative Strength Index (RSI)
  • RBCAA 42.94
  • SYRE 40.66
  • Support Level
  • RBCAA $65.35
  • SYRE $21.61
  • Resistance Level
  • RBCAA $68.30
  • SYRE $23.04
  • Average True Range (ATR)
  • RBCAA 1.63
  • SYRE 1.43
  • MACD
  • RBCAA 0.14
  • SYRE -0.03
  • Stochastic Oscillator
  • RBCAA 44.65
  • SYRE 22.03

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through six reportable segments. It has traditional banking which generates the majority of revenue, warehouse, mortgage banking, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

Share on Social Networks: